PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 4, 2009, Pages 545-552

  Oishi, Katsutaka ^a   Miyazaki, Koyomi ^a   Uchida, Daisuke ^a,b   Ohkura, Naoki ^c   Wakabayashi, Miyuki ^a   Doi, Ryosuke ^a,b   Matsuda, Juzo ^c   Ishida, Norio ^a,b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

BMAL1; Circadian clock; E box; Nuclear localization domain; Obesity; Period2; Plasminogen activator inhibitor 1

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; PER2 PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BMAL1; PROTEIN BMAL2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FIBRINOLYSIS; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSIENT TRANSFECTION; WEIGHT GAIN;

MUS; MUS MUSCULUS;

ANIMALS; ARNTL TRANSCRIPTION FACTORS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BODY WEIGHT; CELL CYCLE PROTEINS; CIRCADIAN RHYTHM; CLOCK PROTEINS; DIETARY FATS; GENE EXPRESSION REGULATION; MICE; MYOCARDIUM; NIH 3T3 CELLS; NUCLEAR PROTEINS; PERIOD CIRCADIAN PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RATS; RNA, MESSENGER; SUCROSE; SUPPRESSION, GENETIC; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 61449266421     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.01.001     Document Type: Article

References (57)

1. De Taeye B., Smith L.H., and Vaughan D.E. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Curr. Opin. Pharmacol. 5 (2005) 149-154
2. Alessi M.C., and Juhan-Vague I. Contribution of PAI-1 in cardiovascular pathology. Arch. Mal. Coeur Vaiss. 97 (2004) 673-678
3. Juhan-Vague I., and Alessi M.C. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb. Haemost. 78 (1997) 656-660
4. Vaughan D.E. PAI-1 and atherothrombosis. J. Thromb. Haemost. 3 (2005) 1879-1883
5. Mutch N.J., Wilson H.M., and Booth N.A. Plasminogen activator inhibitor-1 and haemostasis in obesity. Proc. Nutr. Soc. 60 (2001) 341-347
6. Skurk T., and Hauner H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 1357-1364
7. Manfredini R., Boari B., Smolensky M.H., Salmi R., la Cecilia O., Maria Malagoni A., et al. Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events. Chronobiol. Int. 22 (2005) 417-453
8. Rana J.S., Mukamal K.J., Morgan J.P., Muller J.E., and Mittleman M.A. Circadian variation in the onset of myocardial infarction: effect of duration of diabetes. Diabetes 52 (2003) 1464-1468
9. Guo Y.F., and Stein P.K. Circadian rhythm in the cardiovascular system: chronocardiology. Am. Heart J. 145 (2003) 779-786
10. Yamamoto K., and Saito H. A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders. Int. J. Hematol. 68 (1998) 371-385
11. Andreotti F., and Kluft C. Circadian variation of fibrinolytic activity in blood. Chronobiol. Int. 8 (1991) 336-351
12. Maemura K., de la Monte S.M., Chin M.T., Layne M.D., Hsieh C.M., Yet S.F., et al. CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J. Biol. Chem. 275 (2000) 36847-36851
13. Schoenhard J.A., Smith L.H., Painter C.A., Eren M., Johnson C.H., and Vaughan D.E. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. J. Mol. Cell. Cardiol. 35 (2003) 473-481
14. Wang J., Yin L., and Lazar M.A. The orphan nuclear receptor Rev-erb alpha regulates circadian expression of plasminogen activator inhibitor type 1. J. Biol. Chem. 281 (2006) 33842-33848
15. Oishi K., Shirai H., and Ishida N. Identification of the circadian clock-regulated E-box element in the mouse plasminogen activator inhibitor-1 gene. J. Thromb. Haemost. 5 (2007) 428-431
16. Reppert S.M., and Weaver D.R. Molecular analysis of mammalian circadian rhythms. Annu. Rev. Physiol. 63 (2001) 647-676
17. Reppert S.M., and Weaver D.R. Coordination of circadian timing in mammals. Nature 418 (2002) 935-941
18. Vitaterna M.H., Selby C.P., Todo T., Niwa H., Thompson C., Fruechte E.M., et al. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12114-12119
19. Kume K., Zylka M.J., Sriram S., Shearman L.P., Weaver D.R., Jin X., et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 98 (1999) 193-205
20. Fu L., Pelicano H., Liu J., Huang P., and Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111 (2002) 41-50
21. Chen-Goodspeed M., and Lee C.C. Tumor suppression and circadian function. J. Biol. Rhythms. 22 (2007) 291-298
22. Koyanagi S., Kuramoto Y., Nakagawa H., Aramaki H., Ohdo S., Soeda S., et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 63 (2003) 7277-7283
23. Liu J., Malkani G., Shi X., Meyer M., Cunningham-Runddles S., Ma X., et al. The circadian clock Period 2 gene regulates gamma interferon production of NK cells in host response to lipopolysaccharide-induced endotoxic shock. Infect. Immun. 74 (2006) 4750-4756
24. Viswambharan H., Carvas J.M., Antic V., Marecic A., Jud C., Zaugg C.E., et al. Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation 115 (2007) 2188-2195
25. Sangoram A.M., Saez L., Antoch M.P., Gekakis N., Staknis D., Whiteley A., et al. Mammalian circadian autoregulatory loop: a timeless ortholog and mPer1 interact and negatively regulate CLOCK-BMAL1-induced transcription. Neuron 21 (1998) 1101-1113
26. Jin X., Shearman L.P., Weaver D.R., Zylka M.J., de Vries G.J., and Reppert S.M. A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell 96 (1999) 57-68
27. Zheng B., Larkin D.W., Albrecht U., Sun Z.S., Sage M., Eichele G., et al. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 400 (1999) 169-173
28. Bae K., Jin X., Maywood E.S., Hastings M.H., Reppert S.M., and Weaver D.R. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 30 (2001) 525-536
29. Ohkura N., Oishi K., Fukushima N., Kasamatsu M., Atsumi G.I., Ishida N., et al. Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression. J. Thromb. Haemost. 4 (2006) 2478-2485
30. Oishi K., Ohkura N., Amagai N., and Ishida N. Involvement of circadian clock gene Clock in diabetes-induced circadian augmentation of plasminogen activator inhibitor-1 (PAI-1) expression in the mouse heart. FEBS Lett. 579 (2005) 3555-3559
31. Oishi K., Ohkura N., Wakabayashi M., Shirai H., Sato K., Matsuda J., et al. CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression. J. Thromb. Haemost. 4 (2006) 1774-1780
32. Oishi K., Miyazaki K., Kadota K., Kikuno R., Nagase T., Atsumi G., et al. Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes. J. Biol. Chem. 278 (2003) 41519-41527
33. Rudic R.D., McNamara P., Curtis A.M., Boston R.C., Panda S., Hogenesch J.B., et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol. 2 (2004) e377
34. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308 (2005) 1043-1045
35. Oishi K., Shirai H., and Ishida N. CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice. Biochem. J. 386 (2005) 575-581
36. Oishi K., Atsumi G., Sugiyama S., Kodomari I., Kasamatsu M., Machida K., et al. Disrupted fat absorption attenuates obesity induced by a high-fat diet in Clock mutant mice. FEBS Lett. 580 (2006) 127-130
37. Kudo T., Tamagawa T., Kawashima M., Mito N., and Shibata S. Attenuating effect of clock mutation on triglyceride contents in the ICR mouse liver under a high-fat diet. J. Biol. Rhythms. 22 (2007) 312-323
38. Kobayashi Y., Ishikawa T., Hirayama J., Daiyasu H., Kanai S., Toh H., et al. Molecular analysis of zebrafish photolyase/cryptochrome family: two types of cryptochromes present in zebrafish. Genes Cells 5 (2000) 725-738
39. Miyazaki K., Mesaki M., and Ishida N. Nuclear entry mechanism of rat PER2 (rPER2): role of rPER2 in nuclear localization of CRY protein. Mol. Cell. Biol. 21 (2001) 6651-6659
40. Miyazaki K., Wakabayashi M., Chikahisa S., Sei H., and Ishida N. PER2 controls circadian periods through nuclear localization in the suprachiasmatic nucleus. Genes Cells 12 (2007) 1225-1234
41. Hara Y., Shimada K., Kohga H., Ohara O., and Koga H. High-throughput production of recombinant antigens for mouse KIAA proteins in Escherichia coli: computational allocation of possible antigenic regions, and construction of expression plasmids of glutathione-S-transferase-fused antigens by an in vitro recombination-assisted method. DNA Res. 10 (2003) 129-136
42. Todaro G.J., and Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17 (1963) 299-313
43. Lee C., Etchegaray J.P., Cagampang F.R., Loudon A.S., and Reppert S.M. Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107 (2001) 855-867
44. Yoo S.H., Ko C.H., Lowrey P.L., Buhr E.D., Song E.J., Chang S., et al. A noncanonical E-box enhancer drives mouse Period2 circadian oscillations in vivo. Proc. Natl. Acad. Sci. USA 102 (2005) 2608-2613
45. Triqueneaux G., Thenot S., Kakizawa T., Antoch M.P., Safi R., Takahashi J.S., et al. The orphan receptor Rev-erb alpha gene is a target of the circadian clock pacemaker. J. Mol. Endocrinol. 33 (2004) 585-608
46. Ripperger J.A., and Schibler U. Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat. Genet. 38 (2006) 369-374
47. Schreyer S.A., Vick C., Lystig T.C., Mystkowski P., and LeBoeuf R.C. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E207-214
48. Kirk E.A., Sagawa Z.K., McDonald T.O., O'Brien K.D., and Heinecke J.W. Macrophage chemoattractant protein-1 deficiency fails to restrain macrophage infiltration into adipose tissue. Diabetes 57 (2008) 1254-1261
49. Langmesser S., Tallone T., Bordon A., Rusconi S., and Albrecht U. Interaction of circadian clock proteins PER2 and CRY with BMAL1 and CLOCK. BMC Mol. Biol. 9 (2008) 41
50. Lee C., Weaver D.R., and Reppert S.M. Direct association between mouse PERIOD and CKIepsilon is critical for a functioning circadian clock. Mol. Cell. Biol. 24 (2004) 584-594
51. Yamamoto Y., Yagita K., and Okamura H. Role of cyclic mPer2 expression in the mammalian cellular clock. Mol. Cell. Biol. 25 (2005) 1912-1921
52. Liu A.C., Tran H.G., Zhang E.E., Priest A.A., Welsh D.K., and Kay S.A. Redundant function of REV-ERB alpha and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 4 (2008) e1000023
53. Kornmann B., Schaad O., Bujard H., Takahashi J.S., and Schibler U. System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol. 5 (2007) e34
54. Sobel B.E., Lee Y.H., Pratley R.E., and Schneider D.J. Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age. Life Sci. 79 (2006) 1600-1605
55. Yazdi M., Ahnmark A., William-Olsson L., Snaith M., Turner N., Osla F., et al. The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice. Biochem. Biophys. Res. Commun. 369 (2008) 1065-1070
56. Oishi K., Ohkura N., Kasamatsu M., Fukushima N., Shirai H., Matsuda J., et al. Tissue-specific augmentation of circadian PAI-1 expression in mice with streptozotocin-induced diabetes. Thromb. Res. 114 (2004) 129-135
57. Toh K.L., Jones C.R., He Y., Eide E.J., Hinz W.A., Virshup D.M., et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291 (2001) 1040-1043